121 related articles for article (PubMed ID: 24232915)
41. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
Yang Y; Li X; Yang H; Qian Y; Zhang Y; Fang R; Chen X
Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein.
Rota RP; Palacios CA; Temprana CF; Argüelles MH; Mandile MG; Mattion N; Laimbacher AS; Fraefel C; Castello AA; Glikmann G
J Virol Methods; 2018 Jun; 256():24-31. PubMed ID: 29496429
[TBL] [Abstract][Full Text] [Related]
43. Expression and characterization of human group C rotavirus virus-like particles in insect cells.
Clark KB; Lin SC; Humphrey C; Foytich K; Esona M; Wang Y; Liu M; Jiang B
Virology; 2009 May; 387(2):267-72. PubMed ID: 19285329
[TBL] [Abstract][Full Text] [Related]
44. Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles.
O'Brien GJ; Bryant CJ; Voogd C; Greenberg HB; Gardner RC; Bellamy AR
Virology; 2000 May; 270(2):444-53. PubMed ID: 10793003
[TBL] [Abstract][Full Text] [Related]
45. Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo.
Tamminen K; Heinimäki S; Vesikari T; Blazevic V
J Immunol Res; 2020; 2020():3194704. PubMed ID: 32411793
[TBL] [Abstract][Full Text] [Related]
46. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery.
Zhao Q; Chen W; Chen Y; Zhang L; Zhang J; Zhang Z
Bioconjug Chem; 2011 Mar; 22(3):346-52. PubMed ID: 21338097
[TBL] [Abstract][Full Text] [Related]
47. Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles.
Frenchick PJ; Sabara MI; Ready KF; Babiuk LA
Vaccine; 1992; 10(11):783-91. PubMed ID: 1332271
[TBL] [Abstract][Full Text] [Related]
48. [Optimization of the codon strengthened the human rotavirus VP6 antigen's serum immune responses and protective responses in mice model].
Wang M; Wu F; Song JD; Qu JG; Wang JW; Hong T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):22-4. PubMed ID: 22919745
[TBL] [Abstract][Full Text] [Related]
49. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity.
Hoshino Y; Jones RW; Chanock RM; Kapikian AZ
J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947
[TBL] [Abstract][Full Text] [Related]
50. Topology of bovine rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis.
Tosser G; Delaunay T; Kohli E; Grosclaude J; Pothier P; Cohen J
Virology; 1994 Oct; 204(1):8-16. PubMed ID: 7522377
[TBL] [Abstract][Full Text] [Related]
51. DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice.
Suradhat S; Yoo D; Babiuk LA; Griebel P; Baca-Estrada ME
Viral Immunol; 1997; 10(3):117-27. PubMed ID: 9344334
[TBL] [Abstract][Full Text] [Related]
52. Mapping the subgroup epitopes of rotavirus protein VP6.
López S; Espinosa R; Greenberg HB; Arias CF
Virology; 1994 Oct; 204(1):153-62. PubMed ID: 7522369
[TBL] [Abstract][Full Text] [Related]
53. Increased accumulation and stability of rotavirus VP6 protein in tobacco chloroplasts following changes to the 5' untranslated region and the 5' end of the coding region.
Inka Borchers AM; Gonzalez-Rabade N; Gray JC
Plant Biotechnol J; 2012 May; 10(4):422-34. PubMed ID: 22257338
[TBL] [Abstract][Full Text] [Related]
54. Heterogeneity of Raft-type membrane microdomains associated with VP4, the rotavirus spike protein, in Caco-2 and MA 104 cells.
Delmas O; Breton M; Sapin C; Le Bivic A; Colard O; Trugnan G
J Virol; 2007 Feb; 81(4):1610-8. PubMed ID: 17135322
[TBL] [Abstract][Full Text] [Related]
55. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection.
Dong JL; Liang BG; Jin YS; Zhang WJ; Wang T
Virology; 2005 Sep; 339(2):153-63. PubMed ID: 15992851
[TBL] [Abstract][Full Text] [Related]
56. Projection structure of VP6, the rotavirus inner capsid protein, and comparison with bluetongue VP7.
Hsu GG; Bellamy AR; Yeager M
J Mol Biol; 1997 Sep; 272(3):362-8. PubMed ID: 9325096
[TBL] [Abstract][Full Text] [Related]
57. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
58. [Preliminary study of immunity and safety of recombinant adenovirus expressing rotavirus structural proteins in rhesus monkeys].
Li Y; Jiang QF; Wang JW; Chen Y; Wang M; Li CH; Zhang CH; Dai CB; Yu XP; Dai JJ; Li QH; Hong T
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):2002-6. PubMed ID: 15730817
[TBL] [Abstract][Full Text] [Related]
59. [A Recombinant Rotavirus Antigen Based on the Coat Protein of Alternanthera Mosaic Virus].
Ryabchevskaya EM; Evtushenko EA; Arkhipenko MV; Donchenko EK; Nikitin NA; Atabeko JG; Karpova OV
Mol Biol (Mosk); 2020; 54(2):278-284. PubMed ID: 32392197
[TBL] [Abstract][Full Text] [Related]
60. Rotavirus VP6 protein as a bio-electrochemical scaffold: Molecular dynamics and experimental electrochemistry.
Garcia-Garcia WI; Vidal-Limon A; Arrocha-Arcos AA; Palomares LA; Ramirez OT; Miranda-Hernández M
Bioelectrochemistry; 2019 Jun; 127():180-186. PubMed ID: 30849563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
